February 13, 2018 / 11:54 PM / 10 months ago

BRIEF-Quidel Receives 510(K) Clearance For Quickvue Influenza A+B Test

Feb 13 (Reuters) - Quidel Corp:

* QUIDEL RECEIVES 510(K) CLEARANCE FOR QUICKVUE INFLUENZA A+B TEST, ASSAY MEETS FDA’S CLASS II RIDT REQUIREMENTS

* QUIDEL- ‍IN RECENT CLINICAL STUDY, CO’S QUICKVUE INFLUENZA A+B TEST SHOWN TO MEET FDA RECLASSIFICATION CRITERIA FOR CLASS II RAPID INFLUENZA DIAGNOSTIC TESTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below